{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:29:55Z","timestamp":1793705395772,"version":"4.5.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Eosinophilic gastrointestinal diseases (EGIDs) affecting the gastrointestinal tract outside of the esophagus are categorized as non-EoE EGIDs, and knowledge regarding their natural history and pathophysiology is rapidly advancing. This review synthesizes evolving mechanistic insights in non-EoE EGID immunopathogenesis, emerging paradigms of disease development, and how these insights influence potential therapeutic options for these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>The prevalence of non-EoE EGIDs is rising, though overall prevalence remains much lower than that of eosinophilic esophagitis (EoE). Recent standardization of the nomenclature and histologic diagnostic thresholds for non-EoE EGIDs has facilitated progress in understanding the epidemiology, pathogenesis, and therapeutic targets of these conditions. Transcriptomic signatures of disease in the proximal tract, including the esophagus, stomach, and small intestine, are distinct from those in the colon, suggesting that segment-specific therapeutics may be appropriate. Mechanisms beyond eosinophilic inflammation, including mast cell activation, Th2 cytokine signaling, and structural remodeling, may also contribute to disease pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Mechanistic insights elucidated from extensive transcriptomic studies and clinical trials have revealed the broader type 2 pathophysiology of non-EoE EGIDs, thereby offering a valuable opportunity to identify novel therapeutic targets and inform the design of future clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001629","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:00:36Z","timestamp":1791558036000},"page":"652-658","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insight into eosinophilic enteritis and related disorders"],"prefix":"10.1097","volume":"38","author":[{"given":"Erin P.","family":"Syverson","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajitha D.","family":"Venkatesh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital"},{"name":"Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique D.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children's Hospital"},{"name":"Columbia Center for Human Development, Columbia University Medical Center"},{"name":"Columbia University Digestive and Liver Diseases Research Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"R1-20261103","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.cgh.2022.02.017","article-title":"International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-20261103","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MPG.0000000000003877","article-title":"Joint ESPGHAN\/NASPGHAN Guidelines on childhood eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis","volume":"78","author":"Papadopoulou","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R3-20261103","doi-asserted-by":"crossref","first-page":"100762","DOI":"10.1016\/j.jacig.2026.100762","article-title":"Prevalence and features of eosinophilic gastrointestinal disorders using the large real-world TriNetX database","volume":"5","author":"Miracle","year":"2026","journal-title":"J Allergy Clin Immunol Glob"},{"key":"R4-20261103","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cgh.2011.07.017","article-title":"Natural history of eosinophilic gastroenteritis","volume":"9","author":"de Chambrun","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20261103","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.14309\/ajg.0000000000002644","article-title":"Natural histories and disease complications in a cohort of 151 children with gastric or duodenal eosinophilia","volume":"119","author":"Quinn","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"R6-20261103","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2468-1253(18)30005-0","article-title":"Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus","volume":"3","author":"Walker","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R7-20261103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.14309\/ajg.0000000000002021","article-title":"Eosinophilic gastritis and enteritis are increased in families with eosinophilic esophagitis","volume":"118","author":"Allen-Brady","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"R8-20261103","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2017.05.050","article-title":"Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017","volume":"15","author":"Mansoor","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-20261103","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/ajg.2014.166","article-title":"Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy","volume":"109","author":"Ko","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R10-20261103","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2023.05.024","article-title":"Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial","volume":"152","author":"Gonsalves","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R11-20261103","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20261103","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3389\/fimmu.2018.02624","article-title":"Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy","volume":"9","author":"Wright","year":"2018","journal-title":"Front Immunol"},{"key":"R13-20261103","doi-asserted-by":"crossref","first-page":"102170","DOI":"10.1016\/j.clinre.2023.102170","article-title":"Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases","volume":"47","author":"Jensen","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R14-20261103","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.14309\/ajg.0000000000002303","article-title":"Prenatal, intrapartum, and neonatal factors increase the risk of eosinophilic esophagitis","volume":"118","author":"Kurt","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"R15-20261103","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/jamapediatrics.2023.4609","article-title":"Maternal and infant antibiotic and acid suppressant use and risk of eosinophilic esophagitis","volume":"177","author":"Jensen","year":"2023","journal-title":"JAMA Pediatr"},{"key":"R16-20261103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3164\/jcbn.13-15","article-title":"Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan","volume":"53","author":"Furuta","year":"2013","journal-title":"J Clin Biochem Nutr"},{"key":"R17-20261103","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2025.09.030","article-title":"Epidemiology, natural history, and treatment of eosinophilic gastrointestinal diseases","volume":"170","author":"Visaggi","year":"2026","journal-title":"Gastroenterology"},{"key":"R18-20261103","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPG.0000000000003685","article-title":"Mucosal microbiota associated with eosinophilic esophagitis and eosinophilic gastritis","volume":"76","author":"Furuta","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R19-20261103","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.17845","article-title":"Review article: emerging insights into the epidemiology, pathophysiology, diagnostic and therapeutic aspects of eosinophilic oesophagitis and other eosinophilic gastrointestinal diseases","volume":"59","author":"Low","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-20261103","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1053\/j.gastro.2022.01.022","article-title":"Evaluating eosinophilic colitis as a unique disease using colonic molecular profiles: a multi-site study","volume":"162","author":"Shoda","year":"2022","journal-title":"Gastroenterology"},{"key":"R21-20261103","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jaci.2022.12.814","article-title":"Molecular analysis of duodenal eosinophilia","volume":"151","author":"Shoda","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R22-20261103","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study","volume":"145","author":"Shoda","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R23-20261103","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jaci.2024.03.013","article-title":"Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases","volume":"153","author":"Shoda","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"R24-20261103","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaci.2023.01.021","article-title":"Local type 2 immunity in eosinophilic gastritis","volume":"152","author":"Ben-Baruch Morgenstern","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R25-20261103","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"key":"R26-20261103","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(23)00145-0","article-title":"Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R27-20261103","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.iac.2024.01.004","article-title":"Role of mast cells in eosinophilic gastrointestinal diseases","volume":"44","author":"Khoury","year":"2024","journal-title":"Immunol Allergy Clin North Am"},{"key":"R28-20261103","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.cgh.2020.08.013","article-title":"Mast cell and eosinophil counts in gastric and duodenal biopsy specimens from patients with and without eosinophilic gastroenteritis","volume":"19","author":"Reed","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-20261103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anai.2022.06.015","article-title":"Biologics in eosinophilic gastrointestinal diseases","volume":"130","author":"Dellon","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R30-20261103","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2468-1253(26)00116-0","article-title":"Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial","volume":"11","author":"Gonsalves","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R31-20261103","doi-asserted-by":"crossref","first-page":"e00646","DOI":"10.14309\/ctg.0000000000000646","article-title":"Dupilumab can induce remission of eosinophilic gastritis and duodenitis: a retrospective case series","volume":"15","author":"Sia","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"key":"R32-20261103","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/S0016-5085(25)01292-2","article-title":"Cendakimab efficacy and safety in Japanese adults and adolescents with eosinophilic gastroenteritis: 16-week results from the randomized, placebo-controlled phase 3 trial","volume":"169","author":"Kinoshita","year":"2025","journal-title":"Gastroenterology"},{"key":"R33-20261103","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jaip.2024.02.031","article-title":"Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis","volume":"12","author":"Fu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R34-20261103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(18)30096-7","article-title":"Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study","volume":"3","author":"Shoda","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R35-20261103","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2013.08.046","article-title":"Molecular diagnosis of eosinophilic esophagitis by gene expression profiling","volume":"145","author":"Wen","year":"2013","journal-title":"Gastroenterology"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:00:24Z","timestamp":1793703624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001629","relation":{},"ISSN":["1531-698X","1040-8703"],"issn-type":[{"value":"1531-698X","type":"electronic"},{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}